Home > Drug Search >
  • company_query: Ash Stevens
  •   > 
Drug Filter
Category:
chemistry (22) biology (12)
Status:
Approved (1) Withdrawn (1) NDA Filing (1) Phase Ⅲ (1) Phase Ⅱ (16) Phase Ⅰ (14)
Clinical Stage:
Pending (8) Active (16) Discontinued (8)
Bio-Type:
Gene therapy (5) Cell therapy (1) Oncolytic virus (1) Vaccine (3) Recombinant cytokines (1) Recombinant hormone (1)
Indication:
Acute lymphoblastic leukaemia (ALL) (1) Acute myeloid Leukemia (AML) (1) Anemia (1) Asthma (2) Atopic dermatitis (1) Attention deficit hyperactivity disorder (ADHD) (1) Bladder cancer (1) Varicose veins (1) Coronary artery disease (CAD) (1) Metachromatic leukodystrophy (1) Cystic fibrosis (CF) (1) Neuronal ceroid lipofuscinoses (1) HIV infection (1) Hyperlipidemia (2) Leukemia (1) Major depressive disorder (MDD) (1) Melanoma (1) Myelodysplastic syndrome (MDS) (1) Non small cell lung cancer (NSCLC) (1) Pancreatic cancer (2) Postoperative pain (1) Prostate cancer (4) Psoriasis (2) Schizophrenia (1) Solid tumours (3) Tropical spastic paraparesis (1) Oesophageal varices (1) Pain (1) Methicillin-resistant staphylococcus aureus infections (1) Anaplastic astrocytoma (1) Hemophilia B (1) Hematological cancer (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top